WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical …


Link to Full Article: Read Here

Pin It on Pinterest

Share This